CAD-associated variation at SMAD3, reducing its expression in SMCs, and promoting a fate shift towards a synthetic and inflammatory state, highlights the importance of TGF-β/SMAD signalling in SMC phenotypic regulation [232,233]. The gene discussed is SMAD3; the disease is coronary artery disorder.